Matrix-assisted laser desorption/ionisation time-off-light (MALDI-TOF) mass spectrometry (MS) for the identification of mycobacteria from MBBacT ALERT 3D liquid cultures and Lowenstein-Jensen (LJ) solid cultures

Journal of Clinical Pathology

Volumn 68, Issue 3, 2015, Pages 229-235

  Quinlan, Patricia ^a   Phelan, Elaine ^a   Doyle, Maeve ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL PROTOCOL; LIQUID CULTURE; LOWENSTEIN JENSEN SOLID CULTURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL BIOMASS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM ENGBAEKII; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM HIBERNIAE; MYCOBACTERIUM INTERJECTUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TURNAROUND TIME; BIOMASS; CLASSIFICATION; CULTURE MEDIUM; DEVICES; EQUIPMENT DESIGN; GROWTH, DEVELOPMENT AND AGING; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGICAL EXAMINATION; PROCEDURES; PROTEOMICS; REPRODUCIBILITY; TIME; VALIDATION STUDY; WORKFLOW;

BACTERIAL PROTEIN; CULTURE MEDIUM;

BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BIOMASS; CULTURE MEDIA; EQUIPMENT DESIGN; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; WORKFLOW;

EID: 84923325835     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202374     Document Type: Article

References (28)

1. ECDC/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2013. Stockholm, European Centre for Disease Prevention and Control.
2. National Institute for Health and Clinical Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011;http://guidance.nice.org.uk/CG117/NICEGuidance/pdf/English (accessed 21 Apr 2013).
3. Sougakoff W. Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clin Microbiol Infect 2011;17:800-5.
4. Dheda K, Warren RM, Zumla, et al. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am 2010;24:705-25.
5. Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin in adults. Cochrane Database Syst Rev 2013;(1):CD009593.
6. Marlowe EM, Novak-Weekley SM, Cumpio J, et al. Evaluation of the Cepheid Xpert MTB/RIF Assay for direct detection of Mycobacterium tuberculosis Complex in respiratory specimens. J Clin Microbiol 2011;49:1621-3.
7. Tortoli E, Marcelli F. Use of the INNO LipA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of Rifampin susceptibility. Eur J Clin Microbiol Infect Dis 2007;26:51-5.
8. Crudu V, Stratan E, Romancenco E, et al. First evaluation of an improved assay for Molecular genetic detection of tuberculosis as well as Rifampin and Isoniazid resistances. J Clin Microbiol 2012;50:1264-9.
9. Minonova S, Pimkina E, Kontsevaya I, et al. Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur J Clin Microbiol Infect Dis 2012;31:1381-7.
10. Lacoma A, Garcia-Sierra C, Ruiz-Manano J, et al. GenoType MTBDRplus Assay for molecular detection of Rifampin and Isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2008;46:3660-7.
11. Singh AK, Maurya AK, Kant S, et al. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by novel GenoType® MTBDRsl assay. J Postgrad Med 2013;59:179-85.
12. Balasingham SV, Davidsen T, Szpinda I, et al. Molecular diagnostics in tuberculosis: basis and implications for therapy. Mol Diagn Ther 2009;13:137-51.
13. Gitti Z, Neonakis I, Fanti G, et al. Use of the GenoType Mycobacterium CM and AS assays to analyse 76 Nontuberculous mycobacterial isolates from Greece. J Clin Microbiol 2006;44:2244-6.
14. Russo C, Tortoli E & Menichella D. Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol 2006;44:334-9.
15. Juiz P.M, Almela M, Melcion C, et al. A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012;31:1353-8.
16. Dupont, C, Sivadon-Tardy V, Bille E, et al. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect 2010;16:998-1004.
17. Martiny D, Debaugnies F, Gateff M, et al. Impact of rapid microbial identification directly from positive blood cultures using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry on patient management. Clin Microbiol Infect 2013;19:568-81.
18. Demarco ML, Ford BA. Beyond identification. Emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory. Clin Lab Med 2013;33:611-28.
19. Saleeb PG, Drake SK, Murray PR, et al. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionisation-time of flight mass spectrometry. J Clin Microbiol 2011;49:1790-4.
20. Lotz A, Ferroni A, Beretti JL, et al. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionisation-time of flight mass spectrometry. J Clin Microbiol 2010;48:4481-6.
21. Shitikov E, Ilina E, L. Chernousova, A, et al. Mass spectrometry based methods for the discrimination and typing of mycobacteria. Infect Genet Evol 2012;12:838-45.
22. El Khechine A, Couderc C, Flaudrops C, et al. Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice. PLoS ONE 2011;6;e24720.
23. Balada-Llasat JM, Kamboj K & Pancholi P. Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical laboratory. J Clin Microbiol 2013;51:2875-9.
24. Richter E, Weizenegger M, Fahr AM, et al. Usefulness of the GenoType MTBC Assay for differentiating species of the Mycobacterium tuberculosis Complex in cultures obtained from clinical specimens. J Clin Microbiol 2004;42:4303-6.
25. Zwadyk P, Down JA, Myers N, et al. Rendering of mycobacteria safe for molecular diagnostic studies and development of a lysis method for strand displacement amplification and PCR. J Clin Microbiol 1994;32:2140-6.
26. Bruker Daltonik GmbH. Standard operating procedure: Inactivation and sample preparation procedure for Mycobacteria sp. 2013;Revision 2;1-4.
27. Winn W Jr, Allen S, Janda W, et al. Koneman's color atlas and textbook of diagnostic microbiology. 6th edn, Baltimore, MD, USA: Lippincott Williams & Wilkins, 2006.
28. Culture Service user manual, IMRL, St James hospital, Dublin. http://www.stjames.ie/Departments/DepartmentsA-Z/I/IMRL/DepartmentOverview/2012%20Lpimrl0042.pdf (accessed 2 Dec 2012).